Celltrion Healthcare, Stock Price +0.29% at This Hour... Institutional Investors Net Buy of 200,422 Shares in Last 5 Days

As of 10:32 AM on the 18th, Celltrion Healthcare is trading at 104,500 KRW, up 0.29% from the previous day. The trading volume is 872,468 shares, which is about 27.82% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On August 14, Samsung Securities researcher Seo Geun-hee announced a target price of 130,000 KRW for Celltrion Healthcare, stating, "Operating profit exceeded consensus by 30.7%. Despite COVID-19, profitability improved due to stable growth of European biosimilars compared to the previous quarter and positive sales performance of Truxima in the U.S."

Over the past five days, individual investors have net sold 41,285 shares of Celltrion Healthcare, while foreign investors and institutions have net sold 162,791 shares and net bought 200,422 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.